World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
71
Citations
15562
World Ranking
2349
National Ranking
93

Jean-Jacques Fournié publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Jean-Jacques Fournié sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 265 publications — 56th percentile

56% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Jean-Jacques Fournié D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Jean-Jacques Fournié sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 71 D-Index — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Jean-Jacques Fournié is affiliated with the Federal University of Toulouse Midi-Pyrénées in France and has contributed extensively to research in immunology, microbiology, molecular biology, and medicine. Their work spans a range of interconnected scientific fields and topics, focusing on immune cell function, cancer immunotherapy, and molecular mechanisms underlying disease processes.

The primary fields of study reflected in Fournié's publications include:

  • Immunology and Microbiology
  • Biochemistry, Genetics and Molecular Biology
  • Medicine

Within these broad fields, Fournié has engaged deeply with several subfields, including:

  • Immunology
  • Molecular Biology
  • Oncology
  • Cancer Research
  • Pathology and Forensic Medicine

The scientist's research addresses multiple key topics such as:

  • Immune Cell Function and Interaction
  • T-cell and B-cell Immunology
  • Single-cell and Spatial Transcriptomics
  • Cancer Immunotherapy and Biomarkers
  • CAR-T Cell Therapy Research
  • Epigenetics and DNA Methylation
  • Lymphoma Diagnosis and Treatment

Among Fournié's recent publications are:

  • PD-1 blockade restores helper activity of tumor-infiltrating, exhausted PD-1hiCD39+ CD4 T cells, 2020, JCI Insight
  • Mitochondrial inhibitors circumvent adaptive resistance to venetoclax and cytarabine combination therapy in acute myeloid leukemia, 2021, Nature Cancer
  • Cancer cell adaptability: turning ribonucleoprotein granules into targets, 2021, Trends in Cancer
  • Dual Relief of T-lymphocyte Proliferation and Effector Function Underlies Response to PD-1 Blockade in Epithelial Malignancies, 2020, Cancer Immunology Research
  • Global DNA hypermethylation pattern and unique gene expression signature in liver cancer from patients with Indigenous American ancestry, 2021, Oncotarget

Frequent collaborators in their research include Camille Laurent, Marie Tosolini, Frédéric Pont, Juan-Pablo Cerapio, and Loïc Ysebaert. Collaborations with these researchers indicate a network of partnerships mainly in immunology and cancer research.

Jean-Jacques Fournié's works have appeared primarily in publication venues such as:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cancers
  • Cancer Immunology Research
  • Cell Reports
  • Immunological Reviews

This body of work reflects a focus on understanding immune responses, particularly involving T cells, and investigating mechanisms of cancer resistance and adaptability. Topics such as PD-1 blockade and epigenetic modifications feature prominently, aligned with ongoing developments in immunotherapy and targeted cancer treatment.

Best Publications

  • Stimulation of human gamma delta T cells by nonpeptidic mycobacterial ligands

    Patricia Constant;François Davodeau;Marie-Alix Peyrat;Yannick Poquet

  • Human Solid Tumors Contain High Endothelial Venules: Association with T- and B-Lymphocyte Infiltration and Favorable Prognosis in Breast Cancer

    Ludovic Martinet;Ignacio Garrido;Thomas Filleron;Sophie Le Guellec

  • Differentiation, phenotype, and function of interleukin-17-producing human Vγ9Vδ2 T cells.

    Nadia Caccamo;Carmela La Mendola;Valentina Orlando;Serena Meraviglia

  • Granulysin-Dependent Killing of Intracellular and Extracellular Mycobacterium tuberculosis by Vγ9/Vδ2 T Lymphocytes

    Francesco Dieli;Marita Troye-Blomberg;Juraj Ivanyi;Jean Jacques Fournié

  • Structure of a human gammadelta T-cell antigen receptor.

    Timothy J. Allison;Christine C. Winter;Jean-Jacques Fournié;Marc Bonneville

  • Murine natural killer cells contribute to the granulomatous reaction caused by mycobacterial cell walls

    I. Apostolou;Y. Takahama;C. Belmant;T. Kawano

  • A Phosphorus-Based Dendrimer Targets Inflammation and Osteoclastogenesis in Experimental Arthritis

    Myriam Hayder;Mary Poupot;Michel Baron;Michel Baron;Michel Baron;Delphine Nigon

  • In Vivo Immunomanipulation of Vγ9Vδ2 T Cells with a Synthetic Phosphoantigen in a Preclinical Nonhuman Primate Model

    Hélène Sicard;Sophie Ingoure;Béatrice Luciani;Claire Serraz

  • Early activation of human V gamma 9V delta 2 T cell broad cytotoxicity and TNF production by nonpeptidic mycobacterial ligands.

    F Lang;M A Peyrat;P Constant;F Davodeau

  • Single-cell RNA sequencing unveils the shared and the distinct cytotoxic hallmarks of human TCRVδ1 and TCRVδ2 γδ T lymphocytes.

    Gabriele Pizzolato;Hannah Kaminski;Marie Tosolini;Don-Marc Franchini

  • Human γδ T Cells Induce Dendritic Cell Maturation

    Jamila Ismaili;Jamila Ismaili;Véronique Olislagers;Véronique Olislagers;Rémy Poupot;Rémy Poupot;Jean-Jacques Fournié;Jean-Jacques Fournié

  • Recent Advances in Microwave-Based Dielectric Spectroscopy at the Cellular Level for Cancer Investigations

    Katia Grenier;David Dubuc;Tong Chen;Francois Artis

  • FcγRIII discriminates between 2 subsets of Vγ9Vδ2 effector cells with different responses and activation pathways

    Daniela F. Angelini;Giovanna Borsellino;Mary Poupot;Adamo Diamantini

  • Chemical synthesis and biological activity of bromohydrin pyrophosphate, a potent stimulator of human gamma delta T cells.

    Eric Espinosa;Christian Belmant;Fréderic Pont;Béatrice Luciani

  • CXCR5 Identifies a Subset of Vγ9Vδ2 T Cells which Secrete IL-4 and IL-10 and Help B Cells for Antibody Production

    Nadia Caccamo;Luca Battistini;Marc Bonneville;Fabrizio Poccia

  • CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive V gamma 9V delta 2 T lymphocytes.

    Fabrizio Poccia;Barbara Cipriani;Silvia Vendetti;Vittorio Colizzi

  • What lessons can be learned from γδ T cell-based cancer immunotherapy trials?

    Jean Jacques Fournié;Hélène Sicard;Mary Poupot;Mary Poupot;Mary Poupot;Christine Bezombes;Christine Bezombes;Christine Bezombes

  • Control of self-reactive cytotoxic T lymphocytes expressing γδ T cell receptors by natural killer inhibitory receptors

    Franck Halary;Marie Alix Peyrat;Eric Champagne;Miguel Lopez-Botet

  • Vγ9/Vδ2 T lymphocytes reduce the viability of intracellular Mycobacterium tuberculosis

    Francesco Dieli;Marita Troye-Blomberg;Juraj Ivanyi;Jean Jacques Fournié

  • Bromohydrin pyrophosphate enhances antibody-dependent cell-mediated cytotoxicity induced by therapeutic antibodies.

    Julie Gertner-Dardenne;Julie Gertner-Dardenne;Cecile Bonnafous;Christine Bezombes;Christine Bezombes;Aude-Hélène Capietto;Aude-Hélène Capietto

  • Peripheral V gamma 9/V delta 2 T cell deletion and anergy to nonpeptidic mycobacterial antigens in asymptomatic HIV-1-infected persons.

    F Poccia;S Boullier;H Lecoeur;M Cochet

  • V gamma 9V delta 2 T lymphocytes efficiently recognize and kill zoledronate-sensitized, imatinib-sensitive, and imatinib-resistant chronic myelogenous leukemia cells.

    Matilde D’Asaro;Carmela La Mendola;Diana Di Liberto;Valentina Orlando

Frequent Co-Authors

Marc Bonneville
Marc Bonneville Institut Mérieux (France)
Germain Puzo
Germain Puzo Federal University of Toulouse Midi-Pyrénées
Francesco Dieli
Francesco Dieli University of Palermo
Anne-Marie Caminade
Anne-Marie Caminade Centre national de la recherche scientifique, CNRS
Christian Klein
Christian Klein Roche (Switzerland)
Marie-Lise Gougeon
Marie-Lise Gougeon Institut Pasteur
Luca Battistini
Luca Battistini Albert Einstein College of Medicine
Jean-Pierre Majoral
Jean-Pierre Majoral Centre national de la recherche scientifique, CNRS
Massimo Massaia
Massimo Massaia University of Turin
Els Verhoeyen
Els Verhoeyen Inserm : Institut national de la santé et de la recherche médicale

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees online can open diverse career opportunities. Many programs cater to individuals transitioning into nursing, such as online RN programs for non nurses, designed to accelerate the path to becoming a registered nurse without prior clinical experience.

Accelerated pathways are also available for students who already hold a degree and want to enter the nursing field quickly. The easiest ABSN programs to get into provide rigorous yet accessible options to earn a Bachelor of Science in Nursing efficiently.

For those seeking entry-level practical nursing credentials, LPN programs easy to get into offer practical training and certification with lower barriers to entry. These programs are ideal stepping-stones toward advanced nursing roles.

Finally, advancing to higher clinical responsibilities is possible through easiest nurse practitioner program options. These programs provide enhanced specialization and leadership opportunities in healthcare, complementing a foundational understanding of immunology.

Best Scientists Citing Jean-Jacques Fournié

Trending Scientists

Recently Published Articles